Bringing the fundamentals into focus…
Back to Evommune, Inc.
How Evommune, Inc. stacks up
EVMN · against 251 other Healthcare companies of similar size
Valuation
33/ 100
Below the middle of the pack.
Ranked #124 of 252 · scores higher than 41% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 30–39, including EVMN · Click a bar to see the companies
Why valuation scores 33?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -43.9% vs peer median 1.5%
- Cash exceeds market value plus debt, so EBITDA yield is not meaningful and is left out.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -34.6% vs peer median 0.0%
Metric by metric
Position: dot = EVMN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | EVMN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 235 reported | -199.8% | -1.3% | 0% | 30% | |
| EBITDA yieldHigher is better · 258 reported | -434.7% | 1.4% | 5% | 50% | |
| Free cash flow yieldHigher is better · 144 reported | -34.6% | -12.5% | 23% | 20% | |
| Book yieldHigher is better · 240 reported | 128.8% | 61.4% | 82% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around EVMN| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 1.4B HKD (≈$181M) | 99 | 61 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 124 | 274M USD | 33 | 57 | |
| 124 | 110M USD | 33 | 38 | |
| 124 | 213M USD | 33 | ||
| 124 | 109M USD | 33 | 47 | |
| 124 | 216M USD | 33 | 44 | |
| 124 | 126M USD | 33 | 32 | |
| 124 | 285M USD | 33 | 38 | |
| 124 | 338M USD | 33 | ||
| 124 | 215M USD | 33 | 34 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score